Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.

Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):808-18. doi: 10.1161/CIRCOUTCOMES.112.966168. Epub 2012 Oct 30. Review.

PMID:
23110790
[PubMed - indexed for MEDLINE]
Free Article
2.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

PMID:
19609891
[PubMed - indexed for MEDLINE]
3.

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS.

JAMA. 2012 Sep 12;308(10):1024-33. doi: 10.1001/2012.jama.11374. Review.

PMID:
22968891
[PubMed - indexed for MEDLINE]
4.

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.

Butalia S, Leung AA, Ghali WA, Rabi DM.

Cardiovasc Diabetol. 2011 Apr 1;10:25. doi: 10.1186/1475-2840-10-25. Review.

PMID:
21453547
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group.

Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262. Review.

PMID:
22493407
[PubMed - indexed for MEDLINE]
6.

The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis.

Enns JE, Yeganeh A, Zarychanski R, Abou-Setta AM, Friesen C, Zahradka P, Taylor CG.

BMC Cardiovasc Disord. 2014 May 31;14:70. doi: 10.1186/1471-2261-14-70. Review.

PMID:
24885361
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials.

Ye Y, Li J, Yuan Z.

PLoS One. 2013;8(2):e56803. doi: 10.1371/journal.pone.0056803. Epub 2013 Feb 20.

PMID:
23437244
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.

Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J.

Am J Clin Nutr. 2006 Jul;84(1):5-17. Review.

PMID:
16825676
[PubMed - indexed for MEDLINE]
Free Article
9.

Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis.

Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, Wang C, Xu JF, He J.

PLoS One. 2011;6(9):e25142. doi: 10.1371/journal.pone.0025142. Epub 2011 Sep 28. Review.

PMID:
21980387
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].

Casula M, Soranna D, Catapano AL, Corrao G.

Atheroscler Suppl. 2013 Aug;14(2):243-51. doi: 10.1016/S1567-5688(13)70005-9. Review. Erratum in: Atheroscler Suppl. 2014 Mar;233(1):122.

PMID:
23958480
[PubMed - indexed for MEDLINE]
11.

Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.

Chen Q, Cheng LQ, Xiao TH, Zhang YX, Zhu M, Zhang R, Li K, Wang Y, Li Y.

Cardiovasc Drugs Ther. 2011 Jun;25(3):259-65. doi: 10.1007/s10557-011-6306-8.

PMID:
21626218
[PubMed - indexed for MEDLINE]
12.

Omega-3 fatty acids and cardiovascular risk.

Kruse LG, Ogletree RL Jr.

J Miss State Med Assoc. 2013 Jun;54(6):156-7.

PMID:
23991511
[PubMed - indexed for MEDLINE]
13.

Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.

Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH.

Ann Med. 2009;41(4):301-10. doi: 10.1080/07853890802698834.

PMID:
19148838
[PubMed - indexed for MEDLINE]
14.

Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.

Filion KB, El Khoury F, Bielinski M, Schiller I, Dendukuri N, Brophy JM.

BMC Cardiovasc Disord. 2010 Jun 3;10:24. doi: 10.1186/1471-2261-10-24. Review.

PMID:
20525225
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials.

Yang D, Li J, Yuan Z, Liu X.

PLoS One. 2013 May 8;8(5):e62329. doi: 10.1371/journal.pone.0062329. Print 2013.

PMID:
23667467
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
[PubMed - indexed for MEDLINE]
17.

Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients.

Mills EJ, O'Regan C, Eyawo O, Wu P, Mills F, Berwanger O, Briel M.

Eur Heart J. 2011 Jun;32(11):1409-15. doi: 10.1093/eurheartj/ehr035. Epub 2011 Mar 8. Review.

PMID:
21385791
[PubMed - indexed for MEDLINE]
Free Article
18.

Omega 3 fatty acids for prevention and treatment of cardiovascular disease.

Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, Durrington PN, Ness AR, Capps NE, Davey Smith G, Riemersma RA, Ebrahim SB.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003177. Review.

PMID:
15495044
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Writing Group for the AREDS2 Research Group, Bonds DE, Harrington M, Worrall BB, Bertoni AG, Eaton CB, Hsia J, Robinson J, Clemons TE, Fine LJ, Chew EY.

JAMA Intern Med. 2014 May;174(5):763-71. doi: 10.1001/jamainternmed.2014.328.

PMID:
24638908
[PubMed - indexed for MEDLINE]
20.

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.

Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S; SU.FOL.OM3 Collaborative Group.

BMJ. 2010 Nov 29;341:c6273. doi: 10.1136/bmj.c6273.

PMID:
21115589
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk